Cargando…

Efficacy and Safety of Anticoagulant Therapy Versus Antiplatelet Therapy in Acute Ischemic Stroke Patients with Atrial Fibrillation

The efficacy and safety of anticoagulant therapy in patients with acute ischemic stroke (AIS) and atrial fibrillation (AF) remain uncertain. This study enrolled 431 AIS and AF patients from Nanjing Drum Tower Hospital between January 2019 and December 2021 and followed for 365 days to determine the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Xiaodi, Wang, Baoyan, Xia, Peng, Lan, Chen, Wang, Qian, Ge, Weihong, Zhou, Yujie, Jiang, Chenxiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644758/ https://www.ncbi.nlm.nih.gov/pubmed/37956462 http://dx.doi.org/10.1177/10760296231213070

Ejemplares similares

Anticoagulation versus Antiplatelet Therapy after Ischemic Stroke in the Patients with Atrial Fibrillation and Cerebral Microbleeds
por: Choi, Kang-Ho, et al.
Publicado: (2021)

Oral Anticoagulant and Antiplatelet Therapy for Cervical Artery Dissection: A Meta-Analysis of Clinical Trials
por: Ye, Sheng-Lin, et al.
Publicado: (2021)

Management of Oral Anticoagulation and Antiplatelet Therapy in Post-Myocardial Infarction Patients with Acute Ischemic Stroke with and without Atrial Fibrillation
por: Pezzella, Francesca Romana, et al.
Publicado: (2022)

Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants
por: Purrucker, Jan C., et al.
Publicado: (2020)

Anticoagulant and Antiplatelet Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease
por: Mischke, Karl, et al.
Publicado: (2012)

Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation
por: Seiffge, David J., et al.
Publicado: (2020)

Undertreatment of Anticoagulant Therapy in Hospitalized Acute Ischemic Stroke Patients With Atrial Fibrillation
por: Gong, Xiaoxian, et al.
Publicado: (2022)

Standard-Intensity Versus Low-Intensity Anticoagulation with Warfarin in Asian Patients with Atrial Fibrillation: A Multi-Center, Randomized Controlled Trial
por: Cho, Jeong Gwan, et al.
Publicado: (2023)

Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study
por: Chen, Pei-Chun, et al.
Publicado: (2015)

Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation
por: Meinel, Thomas R., et al.
Publicado: (2020)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome
por: Okuma, Hirohisa, et al.
Publicado: (2009)

An Updated Pooled Analysis of Off-Label Under and Over-Dosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation
por: Shen, Nan-Nan, et al.
Publicado: (2023)

Atrial fibrillation, electroconvulsive therapy, stroke risk, and anticoagulation
por: Kapadia, Meera, et al.
Publicado: (2023)

Prognostic Value of International Normalized Ratio in Ischemic Stroke Patients without Atrial Fibrillation or Anticoagulation Therapy
por: Xie, Xuewei, et al.
Publicado: (2019)

Pacemaker lead malpositioning led to subsequent ischemic strokes despite antiplatelet and anticoagulation therapy
por: Rath, Claus, et al.
Publicado: (2014)

Comparison of Long-Term Outcomes Between Combination Antiplatelet and Anticoagulant Therapy and Anticoagulant Monotherapy in Patients With Atrial Fibrillation and Left Atrial Thrombi
por: Sunaga, Akihiro, et al.
Publicado: (2020)

Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia
por: Yimer, Nuredin Shiferaw, et al.
Publicado: (2021)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Efficacy and Safety of Direct Oral Anticoagulants in Stable Coronary Artery Disease and Atrial Fibrillation: A Systematic Review and Network Meta-Analysis
por: Ma, Fang, et al.
Publicado: (2022)

Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study
por: Srikajornlarp, Saowaluk, et al.
Publicado: (2022)

A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke
por: Amoda, Oluyemisi, et al.
Publicado: (2021)

Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events
por: Warlo, Ellen M. K., et al.
Publicado: (2022)

Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation
por: Chang, Po-Yin, et al.
Publicado: (2021)

Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy
por: Sanders, Carolyn Breauna, et al.
Publicado: (2022)

Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents
por: Bassand, Jean-Pierre
Publicado: (2012)

Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation
por: Chopard, Romain, et al.
Publicado: (2018)

The Comparison of Therapeutic Efficacy Between Dabigatran Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation
por: Li, Hongxia, et al.
Publicado: (2021)

Nomogram Prediction for Lower Extremity Deep Vein Thrombosis in Acute Ischemic Stroke Patients Receiving Thrombolytic Therapy
por: Wang, Yuyan, et al.
Publicado: (2023)

Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes
por: Paciaroni, Maurizio, et al.
Publicado: (2018)

Safety Comparison of Monotherapy Aspirin to Dual Antiplatelet Therapy Following Coronary Artery Bypass Surgery
por: Nei, Scott D., et al.
Publicado: (2022)

Comparing Vitamin K Antagonists and Direct Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis
por: Lee, Wei-Chieh, et al.
Publicado: (2023)

Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation
por: Olivera, Pável, et al.
Publicado: (2023)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
por: Ko, Darae, et al.
Publicado: (2021)

Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion
por: Ge, Heng, et al.
Publicado: (2022)

Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
por: Yoon, Gwang-Seok, et al.
Publicado: (2021)

Clinical Relevance of Anticoagulation and Dual Antiplatelet Therapy to the Outcomes of Patients With Atrial Fibrillation and Recent Percutaneous Coronary Intervention With Stent
por: De Vecchis, Renato, et al.
Publicado: (2016)

Factors Associated with Ischemic Stroke on Therapeutic Anticoagulation in Patients with Nonvalvular Atrial Fibrillation
por: Kim, Young Dae, et al.
Publicado: (2015)

Ischemic Stroke in the Young
por: Berkman, Samuel A., et al.
Publicado: (2021)

Effect of Rabeprazole and Rebamipide in the Treatment of Upper Gastrointestinal Hemorrhage Associated with Dual Antiplatelet Therapy in Elderly Patients with Coronary Heart Disease
por: Jia, Rong-Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_48g4gv43oderbvfhlachrm9ufp